News & Events

January 5, 2023

Minovia Therapeutics appoints Maha Radhakrishnan, Chief Medical Officer at Biogen, as board member Download this news article Read More Read More

January 3, 2023

Minovia Therapeutics to Present at Biotech Showcase on J.P. Morgan Healthcare week Download this news article Read More Read More

December 21, 2022

Minovia Therapeutics Reports in Science Translational Medicine on First Clinical Data Demonstrating Disease-Modifying Efficacy and Safety of Mitochondrial Augmentation Therapy in Pediatric Patients with Primary Mitochondrial Diseases Download this news article Read More Read More

February 28, 2022

The Israeli Company That Develops Treatment for Rare Diseases [Hebrew article] Download this news article Read More Read More

Minovia to Present at Piper Sandler Healthcare Conference for Private Companies on November 29, 2021 Download this news article Read More Read More

September 24, 2021

Minovia’s Preclinical Publication in Nature’s Journal of Regenerative Medicine on the Benefit Conferred by Mitochondrially-augmenetd CD34+ Cells in Patients with Mitochondrial Disorders Download this news article Read More Read More

July 30, 2021

Astellas and Minovia Therapeutics Announce Strategic Collaboration for Novel Mitochondrial Cell Therapy Programs Read More Read More

April 27-29, 2021

Minovia Therapeutics’ CEO Natalie Yivgi-Ohana to present at the Mitochondria-Targeted Drug Development Conference April 27-29, 2021 Read More Read More

March 12, 2021

Minovia Therapeutics Announces Appointment of Alan Jacobs, MSEE, MD, PhD as Chief Medical Officer Download this news article Read More Read More

November 23, 2020

Minovia Therapeutics Announces Manufacturing Partnership with BioSpherix and Appoints David O’Donnell as Global Head of Manufacturing and Supply Chain Download this news article Read More